nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—UGT2B7—urinary bladder cancer	0.432	0.858	CbGaD
Flurbiprofen—PTGS2—urinary bladder cancer	0.0712	0.141	CbGaD
Flurbiprofen—UGT2B7—Epirubicin—urinary bladder cancer	0.0537	0.196	CbGbCtD
Flurbiprofen—ABCC4—Fluorouracil—urinary bladder cancer	0.0444	0.162	CbGbCtD
Flurbiprofen—UGT1A1—Etoposide—urinary bladder cancer	0.0362	0.132	CbGbCtD
Flurbiprofen—ABCC4—Methotrexate—urinary bladder cancer	0.0245	0.0894	CbGbCtD
Flurbiprofen—PTGS2—Cisplatin—urinary bladder cancer	0.0221	0.081	CbGbCtD
Flurbiprofen—PTGS2—Etoposide—urinary bladder cancer	0.0218	0.0795	CbGbCtD
Flurbiprofen—PTGS1—Etoposide—urinary bladder cancer	0.0184	0.0672	CbGbCtD
Flurbiprofen—ALB—Fluorouracil—urinary bladder cancer	0.0164	0.0601	CbGbCtD
Flurbiprofen—SLC22A6—Methotrexate—urinary bladder cancer	0.0106	0.0389	CbGbCtD
Flurbiprofen—ALB—Methotrexate—urinary bladder cancer	0.00907	0.0331	CbGbCtD
Flurbiprofen—CYP2C9—Fluorouracil—urinary bladder cancer	0.00886	0.0324	CbGbCtD
Flurbiprofen—CYP2C9—Cisplatin—urinary bladder cancer	0.00753	0.0275	CbGbCtD
Flurbiprofen—UGT1A1—urine—urinary bladder cancer	0.00343	0.179	CbGeAlD
Flurbiprofen—UGT2B7—prostate gland—urinary bladder cancer	0.00145	0.0754	CbGeAlD
Flurbiprofen—CYP2C9—urine—urinary bladder cancer	0.00144	0.075	CbGeAlD
Flurbiprofen—UGT1A1—prostate gland—urinary bladder cancer	0.00123	0.0641	CbGeAlD
Flurbiprofen—UGT1A9—renal system—urinary bladder cancer	0.00122	0.0637	CbGeAlD
Flurbiprofen—UGT2B7—renal system—urinary bladder cancer	0.000987	0.0514	CbGeAlD
Flurbiprofen—UGT1A1—renal system—urinary bladder cancer	0.000839	0.0437	CbGeAlD
Flurbiprofen—ABCC4—prostate gland—urinary bladder cancer	0.000802	0.0418	CbGeAlD
Flurbiprofen—UGT2B7—female reproductive system—urinary bladder cancer	0.000791	0.0411	CbGeAlD
Flurbiprofen—Suprofen—UGT2B7—urinary bladder cancer	0.000721	0.186	CrCbGaD
Flurbiprofen—Naproxen—UGT2B7—urinary bladder cancer	0.000566	0.146	CrCbGaD
Flurbiprofen—ABCC4—renal system—urinary bladder cancer	0.000547	0.0285	CbGeAlD
Flurbiprofen—PTGS1—prostate gland—urinary bladder cancer	0.000472	0.0246	CbGeAlD
Flurbiprofen—PTGS2—prostate gland—urinary bladder cancer	0.000452	0.0235	CbGeAlD
Flurbiprofen—ABCC4—female reproductive system—urinary bladder cancer	0.000438	0.0228	CbGeAlD
Flurbiprofen—PTGS1—seminal vesicle—urinary bladder cancer	0.0004	0.0208	CbGeAlD
Flurbiprofen—PTGS2—seminal vesicle—urinary bladder cancer	0.000382	0.0199	CbGeAlD
Flurbiprofen—Ibuprofen—UGT2B7—urinary bladder cancer	0.000361	0.0932	CrCbGaD
Flurbiprofen—PTGS1—epithelium—urinary bladder cancer	0.000347	0.0181	CbGeAlD
Flurbiprofen—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000335	0.0174	CbGeAlD
Flurbiprofen—PTGS2—epithelium—urinary bladder cancer	0.000332	0.0173	CbGeAlD
Flurbiprofen—PTGS1—renal system—urinary bladder cancer	0.000322	0.0168	CbGeAlD
Flurbiprofen—PTGS2—smooth muscle tissue—urinary bladder cancer	0.00032	0.0166	CbGeAlD
Flurbiprofen—PTGS2—renal system—urinary bladder cancer	0.000308	0.016	CbGeAlD
Flurbiprofen—PTGS2—urethra—urinary bladder cancer	0.000302	0.0157	CbGeAlD
Flurbiprofen—CYP2C9—female reproductive system—urinary bladder cancer	0.000282	0.0147	CbGeAlD
Flurbiprofen—Oxazepam—UGT2B7—urinary bladder cancer	0.00027	0.0696	CrCbGaD
Flurbiprofen—ALB—lymph node—urinary bladder cancer	0.000265	0.0138	CbGeAlD
Flurbiprofen—PTGS1—female reproductive system—urinary bladder cancer	0.000258	0.0134	CbGeAlD
Flurbiprofen—ABCC4—lymph node—urinary bladder cancer	0.000256	0.0133	CbGeAlD
Flurbiprofen—PTGS2—female reproductive system—urinary bladder cancer	0.000247	0.0128	CbGeAlD
Flurbiprofen—PTGS1—vagina—urinary bladder cancer	0.000233	0.0121	CbGeAlD
Flurbiprofen—PTGS2—vagina—urinary bladder cancer	0.000223	0.0116	CbGeAlD
Flurbiprofen—Ketoprofen—CXCL8—urinary bladder cancer	0.000207	0.0535	CrCbGaD
Flurbiprofen—Ibuprofen—CXCL8—urinary bladder cancer	0.000204	0.0527	CrCbGaD
Flurbiprofen—Carprofen—PTGS2—urinary bladder cancer	0.000192	0.0496	CrCbGaD
Flurbiprofen—Tiaprofenic acid—PTGS2—urinary bladder cancer	0.000157	0.0405	CrCbGaD
Flurbiprofen—PTGS1—lymph node—urinary bladder cancer	0.000151	0.00785	CbGeAlD
Flurbiprofen—PTGS2—lymph node—urinary bladder cancer	0.000144	0.00751	CbGeAlD
Flurbiprofen—Fenbufen—PTGS2—urinary bladder cancer	0.000143	0.0368	CrCbGaD
Flurbiprofen—Ibuprofen—PPARG—urinary bladder cancer	0.000141	0.0364	CrCbGaD
Flurbiprofen—Diflunisal—PTGS2—urinary bladder cancer	0.000137	0.0354	CrCbGaD
Flurbiprofen—Oxaprozin—PTGS2—urinary bladder cancer	0.000124	0.032	CrCbGaD
Flurbiprofen—Salsalate—PTGS2—urinary bladder cancer	0.000124	0.032	CrCbGaD
Flurbiprofen—Suprofen—PTGS2—urinary bladder cancer	0.000119	0.0307	CrCbGaD
Flurbiprofen—Fenoprofen—PTGS2—urinary bladder cancer	0.000102	0.0264	CrCbGaD
Flurbiprofen—Mefenamic acid—PTGS2—urinary bladder cancer	9.5e-05	0.0245	CrCbGaD
Flurbiprofen—Naproxen—PTGS2—urinary bladder cancer	9.33e-05	0.0241	CrCbGaD
Flurbiprofen—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	6.17e-05	0.000528	CcSEcCtD
Flurbiprofen—Decreased appetite—Etoposide—urinary bladder cancer	6.16e-05	0.000527	CcSEcCtD
Flurbiprofen—Pancytopenia—Doxorubicin—urinary bladder cancer	6.14e-05	0.000525	CcSEcCtD
Flurbiprofen—Renal failure—Epirubicin—urinary bladder cancer	6.12e-05	0.000524	CcSEcCtD
Flurbiprofen—Body temperature increased—Cisplatin—urinary bladder cancer	6.11e-05	0.000523	CcSEcCtD
Flurbiprofen—Stomatitis—Epirubicin—urinary bladder cancer	6.07e-05	0.00052	CcSEcCtD
Flurbiprofen—Jaundice—Epirubicin—urinary bladder cancer	6.07e-05	0.00052	CcSEcCtD
Flurbiprofen—Pain—Etoposide—urinary bladder cancer	6.06e-05	0.000519	CcSEcCtD
Flurbiprofen—Constipation—Etoposide—urinary bladder cancer	6.06e-05	0.000519	CcSEcCtD
Flurbiprofen—Conjunctivitis—Epirubicin—urinary bladder cancer	6.05e-05	0.000518	CcSEcCtD
Flurbiprofen—Urinary tract infection—Epirubicin—urinary bladder cancer	6.05e-05	0.000518	CcSEcCtD
Flurbiprofen—Ketoprofen—PTGS2—urinary bladder cancer	6.05e-05	0.0156	CrCbGaD
Flurbiprofen—Dysuria—Doxorubicin—urinary bladder cancer	6.04e-05	0.000517	CcSEcCtD
Flurbiprofen—Neutropenia—Doxorubicin—urinary bladder cancer	6.04e-05	0.000517	CcSEcCtD
Flurbiprofen—Hypersensitivity—Fluorouracil—urinary bladder cancer	6.01e-05	0.000515	CcSEcCtD
Flurbiprofen—Haemoglobin—Methotrexate—urinary bladder cancer	6e-05	0.000514	CcSEcCtD
Flurbiprofen—Haemorrhage—Methotrexate—urinary bladder cancer	5.97e-05	0.000511	CcSEcCtD
Flurbiprofen—Hepatitis—Methotrexate—urinary bladder cancer	5.97e-05	0.000511	CcSEcCtD
Flurbiprofen—Sweating—Epirubicin—urinary bladder cancer	5.97e-05	0.000511	CcSEcCtD
Flurbiprofen—Ibuprofen—PTGS2—urinary bladder cancer	5.95e-05	0.0154	CrCbGaD
Flurbiprofen—Asthenia—Gemcitabine—urinary bladder cancer	5.95e-05	0.00051	CcSEcCtD
Flurbiprofen—Haematuria—Epirubicin—urinary bladder cancer	5.94e-05	0.000508	CcSEcCtD
Flurbiprofen—Pharyngitis—Methotrexate—urinary bladder cancer	5.93e-05	0.000507	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	5.9e-05	0.000505	CcSEcCtD
Flurbiprofen—Epistaxis—Epirubicin—urinary bladder cancer	5.87e-05	0.000503	CcSEcCtD
Flurbiprofen—Pruritus—Gemcitabine—urinary bladder cancer	5.87e-05	0.000503	CcSEcCtD
Flurbiprofen—Nausea—Thiotepa—urinary bladder cancer	5.86e-05	0.000502	CcSEcCtD
Flurbiprofen—Sinusitis—Epirubicin—urinary bladder cancer	5.84e-05	0.0005	CcSEcCtD
Flurbiprofen—Feeling abnormal—Etoposide—urinary bladder cancer	5.84e-05	0.0005	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Doxorubicin—urinary bladder cancer	5.83e-05	0.000499	CcSEcCtD
Flurbiprofen—Agranulocytosis—Epirubicin—urinary bladder cancer	5.81e-05	0.000497	CcSEcCtD
Flurbiprofen—Pneumonia—Doxorubicin—urinary bladder cancer	5.79e-05	0.000496	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Etoposide—urinary bladder cancer	5.79e-05	0.000496	CcSEcCtD
Flurbiprofen—Pruritus—Fluorouracil—urinary bladder cancer	5.77e-05	0.000494	CcSEcCtD
Flurbiprofen—Drowsiness—Doxorubicin—urinary bladder cancer	5.76e-05	0.000493	CcSEcCtD
Flurbiprofen—Visual impairment—Methotrexate—urinary bladder cancer	5.76e-05	0.000493	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	5.71e-05	0.000489	CcSEcCtD
Flurbiprofen—Hypersensitivity—Cisplatin—urinary bladder cancer	5.7e-05	0.000488	CcSEcCtD
Flurbiprofen—Diarrhoea—Gemcitabine—urinary bladder cancer	5.68e-05	0.000486	CcSEcCtD
Flurbiprofen—Renal failure—Doxorubicin—urinary bladder cancer	5.66e-05	0.000485	CcSEcCtD
Flurbiprofen—Erythema multiforme—Methotrexate—urinary bladder cancer	5.65e-05	0.000483	CcSEcCtD
Flurbiprofen—Urticaria—Etoposide—urinary bladder cancer	5.63e-05	0.000482	CcSEcCtD
Flurbiprofen—Haemoglobin—Epirubicin—urinary bladder cancer	5.62e-05	0.000481	CcSEcCtD
Flurbiprofen—Stomatitis—Doxorubicin—urinary bladder cancer	5.62e-05	0.000481	CcSEcCtD
Flurbiprofen—Jaundice—Doxorubicin—urinary bladder cancer	5.62e-05	0.000481	CcSEcCtD
Flurbiprofen—Rhinitis—Epirubicin—urinary bladder cancer	5.6e-05	0.00048	CcSEcCtD
Flurbiprofen—Abdominal pain—Etoposide—urinary bladder cancer	5.6e-05	0.000479	CcSEcCtD
Flurbiprofen—Body temperature increased—Etoposide—urinary bladder cancer	5.6e-05	0.000479	CcSEcCtD
Flurbiprofen—Conjunctivitis—Doxorubicin—urinary bladder cancer	5.6e-05	0.000479	CcSEcCtD
Flurbiprofen—Urinary tract infection—Doxorubicin—urinary bladder cancer	5.6e-05	0.000479	CcSEcCtD
Flurbiprofen—Haemorrhage—Epirubicin—urinary bladder cancer	5.59e-05	0.000479	CcSEcCtD
Flurbiprofen—Hepatitis—Epirubicin—urinary bladder cancer	5.59e-05	0.000479	CcSEcCtD
Flurbiprofen—Diarrhoea—Fluorouracil—urinary bladder cancer	5.58e-05	0.000478	CcSEcCtD
Flurbiprofen—Tinnitus—Methotrexate—urinary bladder cancer	5.57e-05	0.000477	CcSEcCtD
Flurbiprofen—Asthenia—Cisplatin—urinary bladder cancer	5.55e-05	0.000475	CcSEcCtD
Flurbiprofen—Pharyngitis—Epirubicin—urinary bladder cancer	5.55e-05	0.000475	CcSEcCtD
Flurbiprofen—Sweating—Doxorubicin—urinary bladder cancer	5.52e-05	0.000473	CcSEcCtD
Flurbiprofen—Haematuria—Doxorubicin—urinary bladder cancer	5.49e-05	0.00047	CcSEcCtD
Flurbiprofen—Epistaxis—Doxorubicin—urinary bladder cancer	5.43e-05	0.000465	CcSEcCtD
Flurbiprofen—Angiopathy—Methotrexate—urinary bladder cancer	5.42e-05	0.000464	CcSEcCtD
Flurbiprofen—Sinusitis—Doxorubicin—urinary bladder cancer	5.4e-05	0.000463	CcSEcCtD
Flurbiprofen—Dizziness—Fluorouracil—urinary bladder cancer	5.39e-05	0.000462	CcSEcCtD
Flurbiprofen—Visual impairment—Epirubicin—urinary bladder cancer	5.39e-05	0.000461	CcSEcCtD
Flurbiprofen—Agranulocytosis—Doxorubicin—urinary bladder cancer	5.38e-05	0.00046	CcSEcCtD
Flurbiprofen—Chills—Methotrexate—urinary bladder cancer	5.36e-05	0.000459	CcSEcCtD
Flurbiprofen—Diarrhoea—Cisplatin—urinary bladder cancer	5.29e-05	0.000453	CcSEcCtD
Flurbiprofen—Erythema multiforme—Epirubicin—urinary bladder cancer	5.28e-05	0.000452	CcSEcCtD
Flurbiprofen—Alopecia—Methotrexate—urinary bladder cancer	5.28e-05	0.000452	CcSEcCtD
Flurbiprofen—Vomiting—Gemcitabine—urinary bladder cancer	5.27e-05	0.000452	CcSEcCtD
Flurbiprofen—Rash—Gemcitabine—urinary bladder cancer	5.23e-05	0.000448	CcSEcCtD
Flurbiprofen—Dermatitis—Gemcitabine—urinary bladder cancer	5.23e-05	0.000447	CcSEcCtD
Flurbiprofen—Hypersensitivity—Etoposide—urinary bladder cancer	5.22e-05	0.000447	CcSEcCtD
Flurbiprofen—Tinnitus—Epirubicin—urinary bladder cancer	5.21e-05	0.000446	CcSEcCtD
Flurbiprofen—Haemoglobin—Doxorubicin—urinary bladder cancer	5.2e-05	0.000445	CcSEcCtD
Flurbiprofen—Headache—Gemcitabine—urinary bladder cancer	5.2e-05	0.000445	CcSEcCtD
Flurbiprofen—Vomiting—Fluorouracil—urinary bladder cancer	5.19e-05	0.000444	CcSEcCtD
Flurbiprofen—Rhinitis—Doxorubicin—urinary bladder cancer	5.18e-05	0.000444	CcSEcCtD
Flurbiprofen—Haemorrhage—Doxorubicin—urinary bladder cancer	5.17e-05	0.000443	CcSEcCtD
Flurbiprofen—Hepatitis—Doxorubicin—urinary bladder cancer	5.17e-05	0.000443	CcSEcCtD
Flurbiprofen—Rash—Fluorouracil—urinary bladder cancer	5.14e-05	0.00044	CcSEcCtD
Flurbiprofen—Dermatitis—Fluorouracil—urinary bladder cancer	5.14e-05	0.00044	CcSEcCtD
Flurbiprofen—Pharyngitis—Doxorubicin—urinary bladder cancer	5.13e-05	0.000439	CcSEcCtD
Flurbiprofen—Headache—Fluorouracil—urinary bladder cancer	5.11e-05	0.000437	CcSEcCtD
Flurbiprofen—Asthenia—Etoposide—urinary bladder cancer	5.08e-05	0.000435	CcSEcCtD
Flurbiprofen—Angiopathy—Epirubicin—urinary bladder cancer	5.07e-05	0.000434	CcSEcCtD
Flurbiprofen—Chills—Epirubicin—urinary bladder cancer	5.01e-05	0.000429	CcSEcCtD
Flurbiprofen—Pruritus—Etoposide—urinary bladder cancer	5.01e-05	0.000429	CcSEcCtD
Flurbiprofen—Arrhythmia—Epirubicin—urinary bladder cancer	4.99e-05	0.000427	CcSEcCtD
Flurbiprofen—Visual impairment—Doxorubicin—urinary bladder cancer	4.98e-05	0.000427	CcSEcCtD
Flurbiprofen—Alopecia—Epirubicin—urinary bladder cancer	4.94e-05	0.000423	CcSEcCtD
Flurbiprofen—Nausea—Gemcitabine—urinary bladder cancer	4.93e-05	0.000422	CcSEcCtD
Flurbiprofen—Vomiting—Cisplatin—urinary bladder cancer	4.92e-05	0.000421	CcSEcCtD
Flurbiprofen—Erythema multiforme—Doxorubicin—urinary bladder cancer	4.89e-05	0.000419	CcSEcCtD
Flurbiprofen—Rash—Cisplatin—urinary bladder cancer	4.88e-05	0.000417	CcSEcCtD
Flurbiprofen—Dermatitis—Cisplatin—urinary bladder cancer	4.87e-05	0.000417	CcSEcCtD
Flurbiprofen—Diarrhoea—Etoposide—urinary bladder cancer	4.85e-05	0.000415	CcSEcCtD
Flurbiprofen—Nausea—Fluorouracil—urinary bladder cancer	4.84e-05	0.000415	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Methotrexate—urinary bladder cancer	4.82e-05	0.000413	CcSEcCtD
Flurbiprofen—Tinnitus—Doxorubicin—urinary bladder cancer	4.82e-05	0.000413	CcSEcCtD
Flurbiprofen—Anaemia—Methotrexate—urinary bladder cancer	4.81e-05	0.000411	CcSEcCtD
Flurbiprofen—Flatulence—Epirubicin—urinary bladder cancer	4.79e-05	0.00041	CcSEcCtD
Flurbiprofen—Tension—Epirubicin—urinary bladder cancer	4.77e-05	0.000409	CcSEcCtD
Flurbiprofen—Nervousness—Epirubicin—urinary bladder cancer	4.73e-05	0.000405	CcSEcCtD
Flurbiprofen—Angiopathy—Doxorubicin—urinary bladder cancer	4.69e-05	0.000402	CcSEcCtD
Flurbiprofen—Malaise—Methotrexate—urinary bladder cancer	4.69e-05	0.000401	CcSEcCtD
Flurbiprofen—Dizziness—Etoposide—urinary bladder cancer	4.68e-05	0.000401	CcSEcCtD
Flurbiprofen—Vertigo—Methotrexate—urinary bladder cancer	4.67e-05	0.0004	CcSEcCtD
Flurbiprofen—Leukopenia—Methotrexate—urinary bladder cancer	4.65e-05	0.000398	CcSEcCtD
Flurbiprofen—Chills—Doxorubicin—urinary bladder cancer	4.64e-05	0.000397	CcSEcCtD
Flurbiprofen—Arrhythmia—Doxorubicin—urinary bladder cancer	4.62e-05	0.000396	CcSEcCtD
Flurbiprofen—Nausea—Cisplatin—urinary bladder cancer	4.59e-05	0.000393	CcSEcCtD
Flurbiprofen—Alopecia—Doxorubicin—urinary bladder cancer	4.57e-05	0.000391	CcSEcCtD
Flurbiprofen—Cough—Methotrexate—urinary bladder cancer	4.54e-05	0.000388	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Epirubicin—urinary bladder cancer	4.51e-05	0.000387	CcSEcCtD
Flurbiprofen—Convulsion—Methotrexate—urinary bladder cancer	4.5e-05	0.000386	CcSEcCtD
Flurbiprofen—Vomiting—Etoposide—urinary bladder cancer	4.5e-05	0.000386	CcSEcCtD
Flurbiprofen—Anaemia—Epirubicin—urinary bladder cancer	4.5e-05	0.000385	CcSEcCtD
Flurbiprofen—Rash—Etoposide—urinary bladder cancer	4.47e-05	0.000382	CcSEcCtD
Flurbiprofen—Dermatitis—Etoposide—urinary bladder cancer	4.46e-05	0.000382	CcSEcCtD
Flurbiprofen—Headache—Etoposide—urinary bladder cancer	4.44e-05	0.00038	CcSEcCtD
Flurbiprofen—Flatulence—Doxorubicin—urinary bladder cancer	4.44e-05	0.00038	CcSEcCtD
Flurbiprofen—Myalgia—Methotrexate—urinary bladder cancer	4.43e-05	0.000379	CcSEcCtD
Flurbiprofen—Tension—Doxorubicin—urinary bladder cancer	4.42e-05	0.000378	CcSEcCtD
Flurbiprofen—Malaise—Epirubicin—urinary bladder cancer	4.39e-05	0.000376	CcSEcCtD
Flurbiprofen—Discomfort—Methotrexate—urinary bladder cancer	4.37e-05	0.000374	CcSEcCtD
Flurbiprofen—Nervousness—Doxorubicin—urinary bladder cancer	4.37e-05	0.000374	CcSEcCtD
Flurbiprofen—Vertigo—Epirubicin—urinary bladder cancer	4.37e-05	0.000374	CcSEcCtD
Flurbiprofen—Syncope—Epirubicin—urinary bladder cancer	4.36e-05	0.000374	CcSEcCtD
Flurbiprofen—Leukopenia—Epirubicin—urinary bladder cancer	4.36e-05	0.000373	CcSEcCtD
Flurbiprofen—Palpitations—Epirubicin—urinary bladder cancer	4.3e-05	0.000368	CcSEcCtD
Flurbiprofen—Confusional state—Methotrexate—urinary bladder cancer	4.28e-05	0.000366	CcSEcCtD
Flurbiprofen—Loss of consciousness—Epirubicin—urinary bladder cancer	4.28e-05	0.000366	CcSEcCtD
Flurbiprofen—Cough—Epirubicin—urinary bladder cancer	4.25e-05	0.000364	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Methotrexate—urinary bladder cancer	4.24e-05	0.000363	CcSEcCtD
Flurbiprofen—Convulsion—Epirubicin—urinary bladder cancer	4.22e-05	0.000361	CcSEcCtD
Flurbiprofen—Infection—Methotrexate—urinary bladder cancer	4.22e-05	0.000361	CcSEcCtD
Flurbiprofen—Nausea—Etoposide—urinary bladder cancer	4.21e-05	0.00036	CcSEcCtD
Flurbiprofen—Hypertension—Epirubicin—urinary bladder cancer	4.2e-05	0.00036	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Doxorubicin—urinary bladder cancer	4.18e-05	0.000358	CcSEcCtD
Flurbiprofen—Anaemia—Doxorubicin—urinary bladder cancer	4.16e-05	0.000356	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Methotrexate—urinary bladder cancer	4.15e-05	0.000356	CcSEcCtD
Flurbiprofen—Myalgia—Epirubicin—urinary bladder cancer	4.14e-05	0.000355	CcSEcCtD
Flurbiprofen—Anxiety—Epirubicin—urinary bladder cancer	4.13e-05	0.000353	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Methotrexate—urinary bladder cancer	4.1e-05	0.000351	CcSEcCtD
Flurbiprofen—Discomfort—Epirubicin—urinary bladder cancer	4.09e-05	0.00035	CcSEcCtD
Flurbiprofen—Malaise—Doxorubicin—urinary bladder cancer	4.06e-05	0.000348	CcSEcCtD
Flurbiprofen—Dry mouth—Epirubicin—urinary bladder cancer	4.05e-05	0.000347	CcSEcCtD
Flurbiprofen—Vertigo—Doxorubicin—urinary bladder cancer	4.04e-05	0.000346	CcSEcCtD
Flurbiprofen—Anorexia—Methotrexate—urinary bladder cancer	4.04e-05	0.000346	CcSEcCtD
Flurbiprofen—Syncope—Doxorubicin—urinary bladder cancer	4.04e-05	0.000346	CcSEcCtD
Flurbiprofen—Leukopenia—Doxorubicin—urinary bladder cancer	4.03e-05	0.000345	CcSEcCtD
Flurbiprofen—Confusional state—Epirubicin—urinary bladder cancer	4e-05	0.000343	CcSEcCtD
Flurbiprofen—Palpitations—Doxorubicin—urinary bladder cancer	3.98e-05	0.000341	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Epirubicin—urinary bladder cancer	3.97e-05	0.00034	CcSEcCtD
Flurbiprofen—Oedema—Epirubicin—urinary bladder cancer	3.97e-05	0.00034	CcSEcCtD
Flurbiprofen—Hypotension—Methotrexate—urinary bladder cancer	3.96e-05	0.000339	CcSEcCtD
Flurbiprofen—Loss of consciousness—Doxorubicin—urinary bladder cancer	3.96e-05	0.000339	CcSEcCtD
Flurbiprofen—Infection—Epirubicin—urinary bladder cancer	3.94e-05	0.000338	CcSEcCtD
Flurbiprofen—Cough—Doxorubicin—urinary bladder cancer	3.93e-05	0.000336	CcSEcCtD
Flurbiprofen—Shock—Epirubicin—urinary bladder cancer	3.91e-05	0.000334	CcSEcCtD
Flurbiprofen—Convulsion—Doxorubicin—urinary bladder cancer	3.9e-05	0.000334	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Epirubicin—urinary bladder cancer	3.89e-05	0.000333	CcSEcCtD
Flurbiprofen—Hypertension—Doxorubicin—urinary bladder cancer	3.89e-05	0.000333	CcSEcCtD
Flurbiprofen—Tachycardia—Epirubicin—urinary bladder cancer	3.88e-05	0.000332	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	3.87e-05	0.000331	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Epirubicin—urinary bladder cancer	3.84e-05	0.000329	CcSEcCtD
Flurbiprofen—Insomnia—Methotrexate—urinary bladder cancer	3.84e-05	0.000329	CcSEcCtD
Flurbiprofen—Myalgia—Doxorubicin—urinary bladder cancer	3.83e-05	0.000328	CcSEcCtD
Flurbiprofen—Anxiety—Doxorubicin—urinary bladder cancer	3.82e-05	0.000327	CcSEcCtD
Flurbiprofen—Paraesthesia—Methotrexate—urinary bladder cancer	3.81e-05	0.000326	CcSEcCtD
Flurbiprofen—Discomfort—Doxorubicin—urinary bladder cancer	3.79e-05	0.000324	CcSEcCtD
Flurbiprofen—Anorexia—Epirubicin—urinary bladder cancer	3.79e-05	0.000324	CcSEcCtD
Flurbiprofen—Dyspnoea—Methotrexate—urinary bladder cancer	3.78e-05	0.000324	CcSEcCtD
Flurbiprofen—Somnolence—Methotrexate—urinary bladder cancer	3.77e-05	0.000323	CcSEcCtD
Flurbiprofen—Dry mouth—Doxorubicin—urinary bladder cancer	3.75e-05	0.000321	CcSEcCtD
Flurbiprofen—Dyspepsia—Methotrexate—urinary bladder cancer	3.74e-05	0.00032	CcSEcCtD
Flurbiprofen—Hypotension—Epirubicin—urinary bladder cancer	3.71e-05	0.000318	CcSEcCtD
Flurbiprofen—Confusional state—Doxorubicin—urinary bladder cancer	3.7e-05	0.000317	CcSEcCtD
Flurbiprofen—Decreased appetite—Methotrexate—urinary bladder cancer	3.69e-05	0.000316	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Doxorubicin—urinary bladder cancer	3.67e-05	0.000315	CcSEcCtD
Flurbiprofen—Oedema—Doxorubicin—urinary bladder cancer	3.67e-05	0.000315	CcSEcCtD
Flurbiprofen—Infection—Doxorubicin—urinary bladder cancer	3.65e-05	0.000313	CcSEcCtD
Flurbiprofen—Pain—Methotrexate—urinary bladder cancer	3.63e-05	0.000311	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	3.62e-05	0.00031	CcSEcCtD
Flurbiprofen—Shock—Doxorubicin—urinary bladder cancer	3.61e-05	0.000309	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.6e-05	0.000308	CcSEcCtD
Flurbiprofen—Insomnia—Epirubicin—urinary bladder cancer	3.59e-05	0.000307	CcSEcCtD
Flurbiprofen—Tachycardia—Doxorubicin—urinary bladder cancer	3.59e-05	0.000307	CcSEcCtD
Flurbiprofen—Paraesthesia—Epirubicin—urinary bladder cancer	3.57e-05	0.000305	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Doxorubicin—urinary bladder cancer	3.55e-05	0.000304	CcSEcCtD
Flurbiprofen—Dyspnoea—Epirubicin—urinary bladder cancer	3.54e-05	0.000303	CcSEcCtD
Flurbiprofen—Somnolence—Epirubicin—urinary bladder cancer	3.53e-05	0.000302	CcSEcCtD
Flurbiprofen—Anorexia—Doxorubicin—urinary bladder cancer	3.5e-05	0.0003	CcSEcCtD
Flurbiprofen—Feeling abnormal—Methotrexate—urinary bladder cancer	3.5e-05	0.000299	CcSEcCtD
Flurbiprofen—Dyspepsia—Epirubicin—urinary bladder cancer	3.5e-05	0.000299	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Methotrexate—urinary bladder cancer	3.47e-05	0.000297	CcSEcCtD
Flurbiprofen—Decreased appetite—Epirubicin—urinary bladder cancer	3.45e-05	0.000296	CcSEcCtD
Flurbiprofen—Hypotension—Doxorubicin—urinary bladder cancer	3.43e-05	0.000294	CcSEcCtD
Flurbiprofen—Pain—Epirubicin—urinary bladder cancer	3.4e-05	0.000291	CcSEcCtD
Flurbiprofen—Constipation—Epirubicin—urinary bladder cancer	3.4e-05	0.000291	CcSEcCtD
Flurbiprofen—Urticaria—Methotrexate—urinary bladder cancer	3.37e-05	0.000289	CcSEcCtD
Flurbiprofen—Abdominal pain—Methotrexate—urinary bladder cancer	3.35e-05	0.000287	CcSEcCtD
Flurbiprofen—Body temperature increased—Methotrexate—urinary bladder cancer	3.35e-05	0.000287	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	3.35e-05	0.000287	CcSEcCtD
Flurbiprofen—Insomnia—Doxorubicin—urinary bladder cancer	3.32e-05	0.000285	CcSEcCtD
Flurbiprofen—Paraesthesia—Doxorubicin—urinary bladder cancer	3.3e-05	0.000282	CcSEcCtD
Flurbiprofen—Dyspnoea—Doxorubicin—urinary bladder cancer	3.28e-05	0.00028	CcSEcCtD
Flurbiprofen—Feeling abnormal—Epirubicin—urinary bladder cancer	3.27e-05	0.00028	CcSEcCtD
Flurbiprofen—Somnolence—Doxorubicin—urinary bladder cancer	3.27e-05	0.00028	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Epirubicin—urinary bladder cancer	3.25e-05	0.000278	CcSEcCtD
Flurbiprofen—Dyspepsia—Doxorubicin—urinary bladder cancer	3.23e-05	0.000277	CcSEcCtD
Flurbiprofen—Decreased appetite—Doxorubicin—urinary bladder cancer	3.19e-05	0.000273	CcSEcCtD
Flurbiprofen—Urticaria—Epirubicin—urinary bladder cancer	3.15e-05	0.00027	CcSEcCtD
Flurbiprofen—Constipation—Doxorubicin—urinary bladder cancer	3.14e-05	0.000269	CcSEcCtD
Flurbiprofen—Pain—Doxorubicin—urinary bladder cancer	3.14e-05	0.000269	CcSEcCtD
Flurbiprofen—Body temperature increased—Epirubicin—urinary bladder cancer	3.14e-05	0.000269	CcSEcCtD
Flurbiprofen—Abdominal pain—Epirubicin—urinary bladder cancer	3.14e-05	0.000269	CcSEcCtD
Flurbiprofen—Hypersensitivity—Methotrexate—urinary bladder cancer	3.13e-05	0.000268	CcSEcCtD
Flurbiprofen—Asthenia—Methotrexate—urinary bladder cancer	3.04e-05	0.000261	CcSEcCtD
Flurbiprofen—Feeling abnormal—Doxorubicin—urinary bladder cancer	3.03e-05	0.000259	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	3e-05	0.000257	CcSEcCtD
Flurbiprofen—Pruritus—Methotrexate—urinary bladder cancer	3e-05	0.000257	CcSEcCtD
Flurbiprofen—Hypersensitivity—Epirubicin—urinary bladder cancer	2.93e-05	0.00025	CcSEcCtD
Flurbiprofen—Urticaria—Doxorubicin—urinary bladder cancer	2.92e-05	0.00025	CcSEcCtD
Flurbiprofen—Abdominal pain—Doxorubicin—urinary bladder cancer	2.9e-05	0.000249	CcSEcCtD
Flurbiprofen—Body temperature increased—Doxorubicin—urinary bladder cancer	2.9e-05	0.000249	CcSEcCtD
Flurbiprofen—Diarrhoea—Methotrexate—urinary bladder cancer	2.9e-05	0.000249	CcSEcCtD
Flurbiprofen—Asthenia—Epirubicin—urinary bladder cancer	2.85e-05	0.000244	CcSEcCtD
Flurbiprofen—Pruritus—Epirubicin—urinary bladder cancer	2.81e-05	0.000241	CcSEcCtD
Flurbiprofen—Dizziness—Methotrexate—urinary bladder cancer	2.81e-05	0.00024	CcSEcCtD
Flurbiprofen—Diarrhoea—Epirubicin—urinary bladder cancer	2.72e-05	0.000233	CcSEcCtD
Flurbiprofen—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.71e-05	0.000232	CcSEcCtD
Flurbiprofen—Vomiting—Methotrexate—urinary bladder cancer	2.7e-05	0.000231	CcSEcCtD
Flurbiprofen—Rash—Methotrexate—urinary bladder cancer	2.68e-05	0.000229	CcSEcCtD
Flurbiprofen—Dermatitis—Methotrexate—urinary bladder cancer	2.67e-05	0.000229	CcSEcCtD
Flurbiprofen—Headache—Methotrexate—urinary bladder cancer	2.66e-05	0.000228	CcSEcCtD
Flurbiprofen—Asthenia—Doxorubicin—urinary bladder cancer	2.64e-05	0.000226	CcSEcCtD
Flurbiprofen—Dizziness—Epirubicin—urinary bladder cancer	2.63e-05	0.000225	CcSEcCtD
Flurbiprofen—Pruritus—Doxorubicin—urinary bladder cancer	2.6e-05	0.000223	CcSEcCtD
Flurbiprofen—Vomiting—Epirubicin—urinary bladder cancer	2.52e-05	0.000216	CcSEcCtD
Flurbiprofen—Nausea—Methotrexate—urinary bladder cancer	2.52e-05	0.000216	CcSEcCtD
Flurbiprofen—Diarrhoea—Doxorubicin—urinary bladder cancer	2.51e-05	0.000215	CcSEcCtD
Flurbiprofen—Rash—Epirubicin—urinary bladder cancer	2.5e-05	0.000214	CcSEcCtD
Flurbiprofen—Dermatitis—Epirubicin—urinary bladder cancer	2.5e-05	0.000214	CcSEcCtD
Flurbiprofen—Headache—Epirubicin—urinary bladder cancer	2.49e-05	0.000213	CcSEcCtD
Flurbiprofen—Dizziness—Doxorubicin—urinary bladder cancer	2.43e-05	0.000208	CcSEcCtD
Flurbiprofen—Nausea—Epirubicin—urinary bladder cancer	2.36e-05	0.000202	CcSEcCtD
Flurbiprofen—Vomiting—Doxorubicin—urinary bladder cancer	2.34e-05	0.0002	CcSEcCtD
Flurbiprofen—Rash—Doxorubicin—urinary bladder cancer	2.32e-05	0.000198	CcSEcCtD
Flurbiprofen—Dermatitis—Doxorubicin—urinary bladder cancer	2.31e-05	0.000198	CcSEcCtD
Flurbiprofen—Headache—Doxorubicin—urinary bladder cancer	2.3e-05	0.000197	CcSEcCtD
Flurbiprofen—Nausea—Doxorubicin—urinary bladder cancer	2.18e-05	0.000187	CcSEcCtD
Flurbiprofen—ABCC4—Hemostasis—CREBBP—urinary bladder cancer	1.84e-05	0.000221	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	1.82e-05	0.000219	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—IGF1—urinary bladder cancer	1.82e-05	0.000218	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PPARG—urinary bladder cancer	1.81e-05	0.000218	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTO2—urinary bladder cancer	1.81e-05	0.000217	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NAT1—urinary bladder cancer	1.81e-05	0.000217	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—GSTT1—urinary bladder cancer	1.81e-05	0.000217	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.78e-05	0.000214	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—NQO1—urinary bladder cancer	1.77e-05	0.000212	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—CREBBP—urinary bladder cancer	1.74e-05	0.000209	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	1.74e-05	0.000209	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.72e-05	0.000206	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—TYMP—urinary bladder cancer	1.71e-05	0.000205	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PRSS3—urinary bladder cancer	1.7e-05	0.000204	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—RHOA—urinary bladder cancer	1.67e-05	0.0002	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	1.66e-05	0.000199	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—UGT2B7—urinary bladder cancer	1.66e-05	0.000199	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.64e-05	0.000197	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—RRM2—urinary bladder cancer	1.64e-05	0.000196	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—RRM2—urinary bladder cancer	1.64e-05	0.000196	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	1.61e-05	0.000193	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	1.61e-05	0.000193	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	1.6e-05	0.000192	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	1.6e-05	0.000191	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.59e-05	0.000191	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	1.57e-05	0.000188	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—NAT2—urinary bladder cancer	1.55e-05	0.000185	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.54e-05	0.000185	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—LIG1—urinary bladder cancer	1.54e-05	0.000184	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.53e-05	0.000183	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—HPGDS—urinary bladder cancer	1.52e-05	0.000182	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ENO2—urinary bladder cancer	1.52e-05	0.000182	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—HPGDS—urinary bladder cancer	1.52e-05	0.000182	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ENO2—urinary bladder cancer	1.52e-05	0.000182	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.51e-05	0.000181	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—NQO1—urinary bladder cancer	1.5e-05	0.00018	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP4B1—urinary bladder cancer	1.49e-05	0.000179	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.49e-05	0.000178	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	1.48e-05	0.000178	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NAT1—urinary bladder cancer	1.48e-05	0.000178	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—GSTP1—urinary bladder cancer	1.48e-05	0.000177	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GSTT1—urinary bladder cancer	1.47e-05	0.000176	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GSTT1—urinary bladder cancer	1.47e-05	0.000176	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	1.46e-05	0.000175	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.46e-05	0.000175	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.45e-05	0.000174	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PTGS2—urinary bladder cancer	1.43e-05	0.000171	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—IFNA2—urinary bladder cancer	1.42e-05	0.000171	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—SLC19A1—urinary bladder cancer	1.41e-05	0.000169	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—IL2—urinary bladder cancer	1.4e-05	0.000168	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.39e-05	0.000166	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PRSS3—urinary bladder cancer	1.37e-05	0.000165	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—TYMS—urinary bladder cancer	1.37e-05	0.000165	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.36e-05	0.000163	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—TYMP—urinary bladder cancer	1.36e-05	0.000163	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	1.36e-05	0.000163	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—NCOR1—urinary bladder cancer	1.36e-05	0.000163	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—GSTM1—urinary bladder cancer	1.36e-05	0.000163	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—RRM2—urinary bladder cancer	1.34e-05	0.00016	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.33e-05	0.00016	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.3e-05	0.000156	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.3e-05	0.000156	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—GPX1—urinary bladder cancer	1.3e-05	0.000156	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—ERCC2—urinary bladder cancer	1.28e-05	0.000153	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—GSTP1—urinary bladder cancer	1.25e-05	0.00015	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—EP300—urinary bladder cancer	1.25e-05	0.00015	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PTEN—urinary bladder cancer	1.24e-05	0.000149	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.24e-05	0.000149	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ENO2—urinary bladder cancer	1.24e-05	0.000148	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—HPGDS—urinary bladder cancer	1.24e-05	0.000148	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.23e-05	0.000148	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.23e-05	0.000147	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NAT2—urinary bladder cancer	1.23e-05	0.000147	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	1.23e-05	0.000147	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—NQO1—urinary bladder cancer	1.22e-05	0.000147	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—NQO1—urinary bladder cancer	1.22e-05	0.000147	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	1.22e-05	0.000147	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—SRC—urinary bladder cancer	1.22e-05	0.000146	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTT1—urinary bladder cancer	1.2e-05	0.000144	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	0.000144	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—EP300—urinary bladder cancer	1.19e-05	0.000142	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.19e-05	0.000142	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.18e-05	0.000142	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ENO2—urinary bladder cancer	1.17e-05	0.000141	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—TYMS—urinary bladder cancer	1.17e-05	0.00014	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.15e-05	0.000138	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—GSTM1—urinary bladder cancer	1.15e-05	0.000138	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—NCOR1—urinary bladder cancer	1.15e-05	0.000138	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.12e-05	0.000135	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—RBX1—urinary bladder cancer	1.11e-05	0.000133	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—GPX1—urinary bladder cancer	1.1e-05	0.000132	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.1e-05	0.000132	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—TYMP—urinary bladder cancer	1.1e-05	0.000132	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.09e-05	0.000131	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—ERCC2—urinary bladder cancer	1.08e-05	0.00013	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	1.07e-05	0.000128	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—RRM2—urinary bladder cancer	1.06e-05	0.000127	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.05e-05	0.000126	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.03e-05	0.000124	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GSTP1—urinary bladder cancer	1.02e-05	0.000122	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GSTP1—urinary bladder cancer	1.02e-05	0.000122	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	1.02e-05	0.000122	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PLAU—urinary bladder cancer	1.01e-05	0.000121	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—KRAS—urinary bladder cancer	1.01e-05	0.000121	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—NQO1—urinary bladder cancer	9.97e-06	0.000119	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—JAG1—urinary bladder cancer	9.94e-06	0.000119	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NAT2—urinary bladder cancer	9.93e-06	0.000119	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.87e-06	0.000118	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—HPGDS—urinary bladder cancer	9.82e-06	0.000118	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ENO2—urinary bladder cancer	9.82e-06	0.000118	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.76e-06	0.000117	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PPARG—urinary bladder cancer	9.72e-06	0.000117	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.67e-06	0.000116	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTT1—urinary bladder cancer	9.52e-06	0.000114	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—TYMS—urinary bladder cancer	9.48e-06	0.000114	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—TYMS—urinary bladder cancer	9.48e-06	0.000114	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.37e-06	0.000112	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—NCOR1—urinary bladder cancer	9.37e-06	0.000112	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GSTM1—urinary bladder cancer	9.37e-06	0.000112	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GSTM1—urinary bladder cancer	9.37e-06	0.000112	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—NCOR1—urinary bladder cancer	9.37e-06	0.000112	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—CREBBP—urinary bladder cancer	9.34e-06	0.000112	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.02e-06	0.000108	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—TYMP—urinary bladder cancer	8.99e-06	0.000108	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GPX1—urinary bladder cancer	8.97e-06	0.000108	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GPX1—urinary bladder cancer	8.97e-06	0.000108	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—TP53—urinary bladder cancer	8.97e-06	0.000108	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ERCC2—urinary bladder cancer	8.81e-06	0.000106	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ERCC2—urinary bladder cancer	8.81e-06	0.000106	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.63e-06	0.000104	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—HRAS—urinary bladder cancer	8.58e-06	0.000103	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—RRM2—urinary bladder cancer	8.57e-06	0.000103	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.43e-06	0.000101	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—CREBBP—urinary bladder cancer	8.33e-06	9.99e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTP1—urinary bladder cancer	8.31e-06	9.97e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—MTHFR—urinary bladder cancer	8.28e-06	9.93e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—MTHFR—urinary bladder cancer	8.28e-06	9.93e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PPARG—urinary bladder cancer	8.26e-06	9.91e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—IGF1—urinary bladder cancer	8.23e-06	9.86e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NAT2—urinary bladder cancer	8.13e-06	9.75e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.04e-06	9.64e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—HPGDS—urinary bladder cancer	7.94e-06	9.52e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ENO2—urinary bladder cancer	7.94e-06	9.52e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	7.94e-06	9.52e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NQO1—urinary bladder cancer	7.91e-06	9.49e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.89e-06	9.47e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—TYMS—urinary bladder cancer	7.73e-06	9.27e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTT1—urinary bladder cancer	7.7e-06	9.24e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTGS2—urinary bladder cancer	7.65e-06	9.17e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTM1—urinary bladder cancer	7.64e-06	9.16e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—NCOR1—urinary bladder cancer	7.64e-06	9.16e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.58e-06	9.09e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—RHOA—urinary bladder cancer	7.54e-06	9.04e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GPX1—urinary bladder cancer	7.31e-06	8.77e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NCOR1—urinary bladder cancer	7.24e-06	8.68e-05	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.21e-06	8.65e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ERCC2—urinary bladder cancer	7.18e-06	8.61e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—RRM2—urinary bladder cancer	7.02e-06	8.42e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ERCC2—urinary bladder cancer	6.81e-06	8.16e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—MTHFR—urinary bladder cancer	6.75e-06	8.09e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PPARG—urinary bladder cancer	6.72e-06	8.05e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PPARG—urinary bladder cancer	6.72e-06	8.05e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.69e-06	8.03e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTEN—urinary bladder cancer	6.67e-06	7.99e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTP1—urinary bladder cancer	6.6e-06	7.91e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	6.5e-06	7.79e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ENO2—urinary bladder cancer	6.5e-06	7.79e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	6.5e-06	7.79e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.46e-06	7.75e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	6.45e-06	7.73e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CREBBP—urinary bladder cancer	6.45e-06	7.73e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NQO1—urinary bladder cancer	6.4e-06	7.67e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MTHFR—urinary bladder cancer	6.4e-06	7.67e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.38e-06	7.65e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TERT—urinary bladder cancer	6.38e-06	7.65e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—EP300—urinary bladder cancer	6.36e-06	7.62e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—IL2—urinary bladder cancer	6.32e-06	7.58e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	6.3e-06	7.56e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.21e-06	7.45e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.21e-06	7.44e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—TYMS—urinary bladder cancer	6.13e-06	7.36e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTM1—urinary bladder cancer	6.06e-06	7.27e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NCOR1—urinary bladder cancer	6.06e-06	7.27e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FGFR3—urinary bladder cancer	5.86e-06	7.02e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GPX1—urinary bladder cancer	5.81e-06	6.96e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ERCC2—urinary bladder cancer	5.7e-06	6.84e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—EP300—urinary bladder cancer	5.67e-06	6.8e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTEN—urinary bladder cancer	5.67e-06	6.8e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—SRC—urinary bladder cancer	5.52e-06	6.62e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PPARG—urinary bladder cancer	5.47e-06	6.56e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.42e-06	6.49e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—EP300—urinary bladder cancer	5.41e-06	6.48e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—MTHFR—urinary bladder cancer	5.36e-06	6.43e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTP1—urinary bladder cancer	5.34e-06	6.4e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	5.28e-06	6.33e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTGS2—urinary bladder cancer	5.28e-06	6.33e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CREBBP—urinary bladder cancer	5.26e-06	6.31e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NQO1—urinary bladder cancer	5.24e-06	6.28e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.17e-06	6.19e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.08e-06	6.1e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CREBBP—urinary bladder cancer	4.98e-06	5.98e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—TYMS—urinary bladder cancer	4.96e-06	5.95e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTM1—urinary bladder cancer	4.91e-06	5.88e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NCOR1—urinary bladder cancer	4.91e-06	5.88e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GPX1—urinary bladder cancer	4.7e-06	5.63e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ERCC2—urinary bladder cancer	4.61e-06	5.53e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTEN—urinary bladder cancer	4.61e-06	5.52e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTEN—urinary bladder cancer	4.61e-06	5.52e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—KRAS—urinary bladder cancer	4.57e-06	5.48e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—RHOA—urinary bladder cancer	4.51e-06	5.41e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.43e-06	5.32e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—EP300—urinary bladder cancer	4.39e-06	5.27e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—EP300—urinary bladder cancer	4.39e-06	5.27e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	4.37e-06	5.24e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PPARG—urinary bladder cancer	4.35e-06	5.21e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—MTHFR—urinary bladder cancer	4.34e-06	5.2e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTGS2—urinary bladder cancer	4.31e-06	5.16e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.23e-06	5.07e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CREBBP—urinary bladder cancer	4.17e-06	5.01e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ERBB2—urinary bladder cancer	4.17e-06	5.01e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—TYMS—urinary bladder cancer	4.06e-06	4.87e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TP53—urinary bladder cancer	4.06e-06	4.87e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	4.02e-06	4.81e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	4.02e-06	4.81e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—HRAS—urinary bladder cancer	3.88e-06	4.66e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GPX1—urinary bladder cancer	3.85e-06	4.61e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	3.78e-06	4.53e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTEN—urinary bladder cancer	3.76e-06	4.5e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—EP300—urinary bladder cancer	3.58e-06	4.29e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN1A—urinary bladder cancer	3.57e-06	4.28e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PTEN—urinary bladder cancer	3.56e-06	4.27e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	3.55e-06	4.26e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PPARG—urinary bladder cancer	3.52e-06	4.22e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EP300—urinary bladder cancer	3.39e-06	4.07e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CREBBP—urinary bladder cancer	3.38e-06	4.05e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—SRC—urinary bladder cancer	3.3e-06	3.96e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PTEN—urinary bladder cancer	2.98e-06	3.57e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MYC—urinary bladder cancer	2.96e-06	3.55e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EGFR—urinary bladder cancer	2.89e-06	3.47e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.88e-06	3.45e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—EP300—urinary bladder cancer	2.84e-06	3.41e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTGS2—urinary bladder cancer	2.77e-06	3.32e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	2.76e-06	3.31e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—KRAS—urinary bladder cancer	2.73e-06	3.28e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTEN—urinary bladder cancer	2.41e-06	2.89e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HRAS—urinary bladder cancer	2.32e-06	2.79e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—EP300—urinary bladder cancer	2.3e-06	2.76e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.26e-06	2.71e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.97e-06	2.37e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.88e-06	2.26e-05	CbGpPWpGaD
